Arcoma AB (Sweden) Probability of Future Stock Price Finishing Under 1.97
ARCOMA Stock | SEK 10.60 0.05 0.47% |
Arcoma |
Arcoma AB Target Price Odds to finish below 1.97
The tendency of Arcoma Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current Price | Horizon | Target Price | Odds to drop to kr 1.97 or more in 90 days |
10.60 | 90 days | 1.97 | near 1 |
Based on a normal probability distribution, the odds of Arcoma AB to drop to kr 1.97 or more in 90 days from now is near 1 (This Arcoma AB probability density function shows the probability of Arcoma Stock to fall within a particular range of prices over 90 days) . Probability of Arcoma AB price to stay between kr 1.97 and its current price of kr10.6 at the end of the 90-day period is about 12.31 .
Assuming the 90 days trading horizon Arcoma AB has a beta of 0.52. This suggests as returns on the market go up, Arcoma AB average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Arcoma AB will be expected to be much smaller as well. Additionally Arcoma AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Arcoma AB Price Density |
Price |
Predictive Modules for Arcoma AB
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Arcoma AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Arcoma AB Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Arcoma AB is not an exception. The market had few large corrections towards the Arcoma AB's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Arcoma AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Arcoma AB within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.51 | |
β | Beta against Dow Jones | 0.52 | |
σ | Overall volatility | 1.95 | |
Ir | Information ratio | -0.2 |
Arcoma AB Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Arcoma AB for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Arcoma AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Arcoma AB generated a negative expected return over the last 90 days | |
The company reported the revenue of 117.13 M. Net Loss for the year was (7.47 M) with profit before overhead, payroll, taxes, and interest of 55.29 M. | |
Arcoma AB has accumulated about 811 K in cash with (1.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
Roughly 47.0% of the company shares are held by company insiders |
Arcoma AB Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Arcoma Stock often depends not only on the future outlook of the current and potential Arcoma AB's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arcoma AB's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 31.4 M | |
Cash And Short Term Investments | 4.8 M |
Arcoma AB Technical Analysis
Arcoma AB's future price can be derived by breaking down and analyzing its technical indicators over time. Arcoma Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Arcoma AB. In general, you should focus on analyzing Arcoma Stock price patterns and their correlations with different microeconomic environments and drivers.
Arcoma AB Predictive Forecast Models
Arcoma AB's time-series forecasting models is one of many Arcoma AB's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Arcoma AB's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Arcoma AB
Checking the ongoing alerts about Arcoma AB for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Arcoma AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Arcoma AB generated a negative expected return over the last 90 days | |
The company reported the revenue of 117.13 M. Net Loss for the year was (7.47 M) with profit before overhead, payroll, taxes, and interest of 55.29 M. | |
Arcoma AB has accumulated about 811 K in cash with (1.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
Roughly 47.0% of the company shares are held by company insiders |
Other Information on Investing in Arcoma Stock
Arcoma AB financial ratios help investors to determine whether Arcoma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arcoma with respect to the benefits of owning Arcoma AB security.